# FDA Approves HUMANWELL's Generic Drug Application HUMANWELL has received FDA approval for its abbreviated new drug application (ANDA 218740), potentially expanding its portfolio in the competitive generic pharmaceuticals market and enabling the company to capture market share in an established therapeutic category. The approval positions HUMANWELL to leverage generic pricing dynamics and strengthen its position among U.S. generic drugmakers.